At the end of June we had 2.9 quarters of available funds....

At the end of June we had 2.9 quarters of available funds. That's enough to get the company to almost the end of March not allowing for any royalty payments from
Kaken. Even with royalties we are now looking at a CR before FDA approval for SB.
I probably had more faith in management than they were entitled to but the mistakes of management cannot be undone now.
My expectation is that the share price will most likely go back below 12cents maybe even 10 cents before we reach approval for SB. Without funds to proceed with the rest of our pipeline it's going to be a long quiet 9 months with not much to celebrate until next July.